The Asia Pacific Cervical Cancer Diagnostic Market would witness market growth of 5.2% CAGR during the forecast period (2023-2029).
The prevalence of cervical cancer around the region is rising, which has increased the demand for diagnostic procedures like colposcopy and pelvic exams to provide doctors with a better picture of the abnormal tissues. In addition, women with cervical cancer symptoms and indicators can receive assistance from diagnostic facilities to undergo various diagnostic tests, including pap and HPV testing. The increased use of some of the most cutting-edge methods for cervical cancer diagnosis in these facilities will also accelerate the market's growth.
Favorable government initiatives for cervical cancer prevention, the rising incidence of cervical cancer, rising awareness of early detection, and strong R&D from major players in cervical cancer diagnosis and drugs are the main drivers of the market growth. Organizations are starting training programs for gynecologists and nurses to identify cervical cancer cases at an early stage. These initiatives aid in the early detection and treatment of cervical cancer, which is beneficial for market expansion. The market is also anticipated to rise as more effective combination medications and tests are introduced.
Cervical cancer comprised 18.3% (123,907) of new cases and 9.4% of all cancer cases in India in 2020. It continues to be one of the more prevalent malignancies in India and is the main reason women die from cancer in low- and middle-income countries like India. Cervical cancer is the second biggest cause of cancer deaths for women in 12 Indian states, even though the age-standardized incidence rate declined significantly by 39.7% (95% UI 265-57.3) between 1990 and 2016. Hence with the rising prevalence of cervical cancer, the utilization of various diagnostics will surge, boosting the market growth in the APAC region.
The China market dominated the Asia Pacific Cervical Cancer Diagnostic Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $775.5 Million by 2029. The Japan market is exhibiting a CAGR of 4.6% during (2023 - 2029). Additionally, The India market would showcase a CAGR of 5.9% during (2023 - 2029).
Based on Type, the market is segmented into Pap Smear Tests, Colposcopy Tests, HPV Test, Biopsy & ECC, and Others. Based on Age Group, the market is segmented into 20 to 40 years, and Above 40 years. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cervical Cancer Diagnostic Market is Projected to reach USD 10.2 Billion by 2029, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Carl Zeiss AG, CooperSurgical, Inc. (The Cooper Companies, Inc.), DYSIS Medical, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Qiagen N.V., Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Pap Smear Tests
- Colposcopy Tests
- HPV Test
- Biopsy & ECC
- Others
By Age Group
- 20 to 40 years
- Above 40 years
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Becton, Dickinson and Company
- Carl Zeiss AG
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- DYSIS Medical, Inc.
- F.Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Qiagen N.V.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cervical Cancer Diagnostic Market, by Type
1.4.2 Asia Pacific Cervical Cancer Diagnostic Market, by Age Group
1.4.3 Asia Pacific Cervical Cancer Diagnostic Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.1.1 Partnerships, Collaborations and Agreements
3.1.2 Product Launches and Product Expansions
3.1.3 Acquisition and Mergers
3.1.4 Approvals and Trials
3.1.5 Geographical and Business Expansions
3.2 Top Winning Strategies
3.2.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Asia Pacific Cervical Cancer Diagnostic Market by Type
4.1 Asia Pacific Pap Smear Tests Market by Country
4.2 Asia Pacific Colposcopy Tests Market by Country
4.3 Asia Pacific HPV Test Market by Country
4.4 Asia Pacific Biopsy & ECC Market by Country
4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Cervical Cancer Diagnostic Market by Age Group
5.1 Asia Pacific 20 to 40 years Market by Country
5.2 Asia Pacific Above 40 years Market by Country
Chapter 6. Asia Pacific Cervical Cancer Diagnostic Market by Country
6.1 China Cervical Cancer Diagnostic Market
6.1.1 China Cervical Cancer Diagnostic Market by Type
6.1.2 China Cervical Cancer Diagnostic Market by Age Group
6.2 Japan Cervical Cancer Diagnostic Market
6.2.1 Japan Cervical Cancer Diagnostic Market by Type
6.2.2 Japan Cervical Cancer Diagnostic Market by Age Group
6.3 India Cervical Cancer Diagnostic Market
6.3.1 India Cervical Cancer Diagnostic Market by Type
6.3.2 India Cervical Cancer Diagnostic Market by Age Group
6.4 South Korea Cervical Cancer Diagnostic Market
6.4.1 South Korea Cervical Cancer Diagnostic Market by Type
6.4.2 South Korea Cervical Cancer Diagnostic Market by Age Group
6.5 Singapore Cervical Cancer Diagnostic Market
6.5.1 Singapore Cervical Cancer Diagnostic Market by Type
6.5.2 Singapore Cervical Cancer Diagnostic Market by Age Group
6.6 Malaysia Cervical Cancer Diagnostic Market
6.6.1 Malaysia Cervical Cancer Diagnostic Market by Type
6.6.2 Malaysia Cervical Cancer Diagnostic Market by Age Group
6.7 Rest of Asia Pacific Cervical Cancer Diagnostic Market
6.7.1 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Type
6.7.2 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Age Group
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Becton, Dickinson and Company
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 Carl Zeiss AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 CooperSurgical, Inc. (The Cooper Companies, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 DYSIS Medical, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Product Launches and Product Expansions:
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.6.5.3 Acquisition and Mergers:
7.7 Hologic, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Product Launches and Product Expansions:
7.7.5.3 Geographical Expansions:
7.8 Qiagen N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.8.5.2 Product Launches and Product Expansions:
7.8.5.3 Acquisition and Mergers:
7.9 Siemens Healthineers AG (Siemens AG)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Thermo Fisher Scientific, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis
TABLE 1 Asia Pacific Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cervical Cancer Diagnostic Market
TABLE 4 Product Launches And Product Expansions– Cervical Cancer Diagnostic Market
TABLE 5 Acquisition and Mergers– Cervical Cancer Diagnostic Market
TABLE 6 Approvals and trials– Cervical Cancer Diagnostic Market
TABLE 7 Geographical and Business Expansions– Cervical Cancer Diagnostic Market
TABLE 8 Asia Pacific Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 9 Asia Pacific Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 10 Asia Pacific Pap Smear Tests Market by Country, 2019 - 2022, USD Million
TABLE 11 Asia Pacific Pap Smear Tests Market by Country, 2023 - 2029, USD Million
TABLE 12 Asia Pacific Colposcopy Tests Market by Country, 2019 - 2022, USD Million
TABLE 13 Asia Pacific Colposcopy Tests Market by Country, 2023 - 2029, USD Million
TABLE 14 Asia Pacific HPV Test Market by Country, 2019 - 2022, USD Million
TABLE 15 Asia Pacific HPV Test Market by Country, 2023 - 2029, USD Million
TABLE 16 Asia Pacific Biopsy & ECC Market by Country, 2019 - 2022, USD Million
TABLE 17 Asia Pacific Biopsy & ECC Market by Country, 2023 - 2029, USD Million
TABLE 18 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 19 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 20 Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 21 Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 22 Asia Pacific 20 to 40 years Market by Country, 2019 - 2022, USD Million
TABLE 23 Asia Pacific 20 to 40 years Market by Country, 2023 - 2029, USD Million
TABLE 24 Asia Pacific Above 40 years Market by Country, 2019 - 2022, USD Million
TABLE 25 Asia Pacific Above 40 years Market by Country, 2023 - 2029, USD Million
TABLE 26 Asia Pacific Cervical Cancer Diagnostic Market by Country, 2019 - 2022, USD Million
TABLE 27 Asia Pacific Cervical Cancer Diagnostic Market by Country, 2023 - 2029, USD Million
TABLE 28 China Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 29 China Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 30 China Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 31 China Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 32 China Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 33 China Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 34 Japan Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 35 Japan Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 36 Japan Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 37 Japan Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 38 Japan Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 39 Japan Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 40 India Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 41 India Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 42 India Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 43 India Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 44 India Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 45 India Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 46 South Korea Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 47 South Korea Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 48 South Korea Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 49 South Korea Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 50 South Korea Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 51 South Korea Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 52 Singapore Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 53 Singapore Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 54 Singapore Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 55 Singapore Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 56 Singapore Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 57 Singapore Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 58 Malaysia Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 59 Malaysia Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 60 Malaysia Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 61 Malaysia Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 62 Malaysia Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 63 Malaysia Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 64 Rest of Asia Pacific Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 65 Rest of Asia Pacific Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 66 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 67 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 68 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 69 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 70 Key Information – Abbott Laboratories
TABLE 71 Key information – Becton, Dickinson and Company
TABLE 72 key Information – Carl Zeiss AG
TABLE 73 Key Information – CooperSurgical, Inc.
TABLE 74 Key information – DYSIS Medical, Inc.
TABLE 75 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 76 Key Information – Hologic, Inc.
TABLE 77 Key Information – Qiagen N.V.
TABLE 78 Key Information – Siemens Healthineers AG
TABLE 79 Key Information – Thermo Fisher Scientific, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Asia Pacific Cervical Cancer Diagnostic Market share by Type, 2022
FIG 5 Asia Pacific Cervical Cancer Diagnostic Market share by Type, 2029
FIG 6 Asia Pacific Cervical Cancer Diagnostic Market by Type, 2019 - 2029, USD Million
FIG 7 Asia Pacific Cervical Cancer Diagnostic Market share by Age Group, 2022
FIG 8 Asia Pacific Cervical Cancer Diagnostic Market share by Age Group, 2029
FIG 9 Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2019 - 2029, USD Million
FIG 10 Asia Pacific Cervical Cancer Diagnostic Market share by Country, 2022
FIG 11 Asia Pacific Cervical Cancer Diagnostic Market share by Country, 2029
FIG 12 Asia Pacific Cervical Cancer Diagnostic Market by Country, 2019 - 2029, USD Million
FIG 13 Swot analysis: Abbott laboratories
FIG 14 Recent strategies and developments: Becton, Dickinson and Company
FIG 15 Swot analysis: Becton, Dickinson and company
FIG 16 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 17 Recent strategies and developments: Hologic, Inc.
FIG 18 Recent strategies and developments: Qiagen N.V.
FIG 19 Swot analysis: Siemens AG
FIG 20 Swot analysis: thermo fisher scientific, inc.